Literature DB >> 29475957

An isomerase completes the circuit for a redox switch.

Gustavo Salinas1.   

Abstract

The activity of human transglutaminase 2 (TG2), which forms protein cross-links between glutamine and lysine residues, is controlled by an allosteric disulfide bond. However, the mechanism by which this bond is formed, like many systems regulated by oxidative cysteine modifications, was not clear. A new study from Khosla and colleagues shows that TG2 is oxidatively inactivated by the protein disulfide isomerase ERp57, providing the first example of a defined and reversible protein-controlled redox switch and pointing to new strategies to inhibit undesirable TG2 activity in pathological states.
© 2018 Salinas.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29475957      PMCID: PMC5827431          DOI: 10.1074/jbc.H118.001807

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2.

Authors:  Michael C Yi; Arek V Melkonian; James A Ousey; Chaitan Khosla
Journal:  J Biol Chem       Date:  2018-01-05       Impact factor: 5.157

2.  Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.

Authors:  O Molberg; S N Mcadam; R Körner; H Quarsten; C Kristiansen; L Madsen; L Fugger; H Scott; O Norén; P Roepstorff; K E Lundin; H Sjöström; L M Sollid
Journal:  Nat Med       Date:  1998-06       Impact factor: 53.440

Review 3.  Control of blood proteins by functional disulfide bonds.

Authors:  Diego Butera; Kristina M Cook; Joyce Chiu; Jason W H Wong; Philip J Hogg
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

Review 4.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

5.  Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine: IMPLICATIONS FOR CELIAC DISEASE.

Authors:  Nicholas M Plugis; Brad A Palanski; Chih-Hisang Weng; Megan Albertelli; Chaitan Khosla
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

Review 6.  Control of mature protein function by allosteric disulfide bonds.

Authors:  Iman Azimi; Jason W H Wong; Philip J Hogg
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

7.  Activation of extracellular transglutaminase 2 by thioredoxin.

Authors:  Xi Jin; Jorunn Stamnaes; Cornelius Klöck; Thomas R DiRaimondo; Ludvig M Sollid; Chaitan Khosla
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

8.  Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.

Authors:  Rasmus Iversen; Simon Mysling; Kathrin Hnida; Thomas J D Jørgensen; Ludvig M Sollid
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

9.  Transglutaminase 2 undergoes a large conformational change upon activation.

Authors:  Daniel M Pinkas; Pavel Strop; Axel T Brunger; Chaitan Khosla
Journal:  PLoS Biol       Date:  2007-12       Impact factor: 8.029

  9 in total
  1 in total

Review 1.  ERp57/PDIA3: new insight.

Authors:  Silvia Chichiarelli; Fabio Altieri; Giuliano Paglia; Elisabetta Rubini; Marco Minacori; Margherita Eufemi
Journal:  Cell Mol Biol Lett       Date:  2022-02-02       Impact factor: 5.787

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.